Antineoplastic Combined Chemotherapy ProtocolsLeukemiaLeukemia, Myeloid, AcutePoint MutationMutation, MissenseChemotherapy, AdjuvantMutationLeukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidAntineoplastic AgentsLeukemia, ExperimentalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFrameshift MutationCombined Modality TherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaTreatment OutcomeLeukemia Virus, MurineCisplatinCyclophosphamideDoxorubicinGerm-Line MutationPrognosisDisease-Free SurvivalBase SequenceSurvival AnalysisLeukemia, T-CellBreast NeoplasmsPedigreeEtoposideLeukemia, Monocytic, AcuteCytarabineSurvival RateNeoadjuvant TherapyMolecular Sequence DataPolymerase Chain ReactionDrug Resistance, NeoplasmNeoplasm StagingMoloney murine leukemia virusLung NeoplasmsMethotrexateLeukemia, Hairy CellLeukemia L1210Leukemia, B-CellDrug Administration ScheduleMutation RateExonsLeukemia Virus, BovineDNA Mutational AnalysisGene Expression Regulation, LeukemicLeukemia Virus, FelineLeukemia, Radiation-InducedHeterozygoteAmino Acid SubstitutionCell LineNeoplasmsAmino Acid SequenceInduction ChemotherapyTime FactorsAllelesCell Line, TumorAntimetabolites, AntineoplasticDaunorubicinCarboplatinPaclitaxelNeoplasm Recurrence, LocalMyeloid-Lymphoid Leukemia ProteinVinblastineTumor Cells, CulturedGenotypeBone MarrowPolymorphism, Single-Stranded ConformationalDNA-Binding ProteinsFollow-Up StudiesLeukemia P388Mutagenesis, Site-DirectedApoptosisAcute DiseaseRecurrenceLymphomaTaxoidsNeoplasm ProteinsLeukemia, Biphenotypic, AcutePhenotypeDNA, NeoplasmOvarian NeoplasmsTranscription FactorsSequence Analysis, DNAIfosfamideMutagenesisSalvage TherapyBleomycinLeukemia-Lymphoma, Adult T-CellHomozygoteAntineoplastic Agents, AlkylatingDNA PrimersDeoxycytidineHL-60 CellsLymphoma, Non-HodgkinAnthracyclinesRNA, Messenger